Samantha A. Spencer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 12 | 2021 | 454 | 2.460 |
Why?
|
| Musculoskeletal Abnormalities | 4 | 2020 | 95 | 1.430 |
Why?
|
| Oligodendroglia | 2 | 2022 | 517 | 1.210 |
Why?
|
| Pathology, Clinical | 3 | 2021 | 368 | 1.020 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 3 | 2020 | 68 | 1.010 |
Why?
|
| Lipoma | 4 | 2020 | 334 | 0.960 |
Why?
|
| Synostosis | 2 | 2021 | 43 | 0.930 |
Why?
|
| Nevus | 3 | 2020 | 204 | 0.910 |
Why?
|
| Tarsal Bones | 2 | 2021 | 65 | 0.900 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2020 | 91 | 0.710 |
Why?
|
| Zebrafish | 3 | 2022 | 2994 | 0.550 |
Why?
|
| Pain | 7 | 2021 | 4986 | 0.540 |
Why?
|
| Muscular Diseases | 1 | 2020 | 556 | 0.520 |
Why?
|
| Lower Extremity | 3 | 2021 | 1158 | 0.450 |
Why?
|
| Osteotomy | 5 | 2014 | 822 | 0.430 |
Why?
|
| Musculoskeletal Diseases | 2 | 2016 | 581 | 0.410 |
Why?
|
| Flatfoot | 1 | 2012 | 55 | 0.410 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2012 | 94 | 0.400 |
Why?
|
| Cryosurgery | 1 | 2016 | 453 | 0.390 |
Why?
|
| Epiphyses, Slipped | 3 | 2009 | 87 | 0.370 |
Why?
|
| Osteochondrodysplasias | 2 | 2021 | 183 | 0.340 |
Why?
|
| Homeostasis | 1 | 2020 | 3340 | 0.330 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 1095 | 0.320 |
Why?
|
| Rectum | 1 | 2013 | 904 | 0.320 |
Why?
|
| Neural Crest | 2 | 2021 | 275 | 0.320 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 315 | 0.320 |
Why?
|
| Clubfoot | 3 | 2014 | 63 | 0.310 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1486 | 0.300 |
Why?
|
| Muscle, Skeletal | 2 | 2020 | 4931 | 0.290 |
Why?
|
| Achondroplasia | 2 | 2016 | 26 | 0.270 |
Why?
|
| Foramen Magnum | 2 | 2016 | 36 | 0.270 |
Why?
|
| Veins | 3 | 2021 | 770 | 0.270 |
Why?
|
| Colon | 1 | 2013 | 1772 | 0.250 |
Why?
|
| Hip Dislocation, Congenital | 2 | 2008 | 225 | 0.250 |
Why?
|
| Metatarsal Bones | 2 | 2016 | 107 | 0.250 |
Why?
|
| Zebrafish Proteins | 2 | 2021 | 1005 | 0.240 |
Why?
|
| Femur Head | 1 | 2006 | 301 | 0.240 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 1206 | 0.240 |
Why?
|
| Fracture Fixation | 2 | 2016 | 354 | 0.240 |
Why?
|
| Arthroplasty | 1 | 2006 | 305 | 0.230 |
Why?
|
| JC Virus | 1 | 2023 | 85 | 0.230 |
Why?
|
| Polyomavirus | 1 | 2023 | 248 | 0.220 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2023 | 134 | 0.210 |
Why?
|
| Child | 27 | 2021 | 77709 | 0.200 |
Why?
|
| Tibia | 3 | 2021 | 1077 | 0.200 |
Why?
|
| Carcinoma | 1 | 2013 | 2375 | 0.200 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 197 | 0.200 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 2541 | 0.200 |
Why?
|
| Osteochondroma | 1 | 2021 | 47 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3703 | 0.190 |
Why?
|
| Epiphyses | 1 | 2021 | 189 | 0.180 |
Why?
|
| Myelin Sheath | 1 | 2022 | 652 | 0.160 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 336 | 0.160 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2020 | 252 | 0.160 |
Why?
|
| Knee Joint | 2 | 2021 | 1680 | 0.160 |
Why?
|
| Choroid | 1 | 2020 | 322 | 0.160 |
Why?
|
| Dissection | 1 | 2020 | 295 | 0.160 |
Why?
|
| Enbucrilate | 1 | 2018 | 31 | 0.160 |
Why?
|
| Fractures, Bone | 3 | 2016 | 1947 | 0.160 |
Why?
|
| Retrospective Studies | 25 | 2021 | 77449 | 0.150 |
Why?
|
| Subtalar Joint | 1 | 2017 | 32 | 0.150 |
Why?
|
| Varicose Veins | 1 | 2018 | 154 | 0.140 |
Why?
|
| External Fixators | 1 | 2016 | 94 | 0.140 |
Why?
|
| Upper Extremity | 2 | 2019 | 648 | 0.140 |
Why?
|
| Neoplasms | 3 | 2021 | 21683 | 0.140 |
Why?
|
| Orthopedic Procedures | 3 | 2014 | 1288 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2015 | 1416 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2022 | 838 | 0.140 |
Why?
|
| Adolescent | 23 | 2021 | 85781 | 0.130 |
Why?
|
| Skull | 1 | 2020 | 813 | 0.130 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2016 | 89 | 0.130 |
Why?
|
| Leg | 1 | 2021 | 1116 | 0.130 |
Why?
|
| Foot Deformities, Congenital | 1 | 2015 | 59 | 0.130 |
Why?
|
| Humans | 45 | 2023 | 744343 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 640 | 0.130 |
Why?
|
| Lung | 1 | 2013 | 9856 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5221 | 0.120 |
Why?
|
| Foot Injuries | 1 | 2016 | 148 | 0.120 |
Why?
|
| Talus | 2 | 2015 | 72 | 0.120 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2016 | 156 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2023 | 1563 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2013 | 1695 | 0.120 |
Why?
|
| Femur | 4 | 2021 | 1297 | 0.120 |
Why?
|
| Treatment Outcome | 14 | 2021 | 63114 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2938 | 0.120 |
Why?
|
| Tibial Fractures | 1 | 2016 | 269 | 0.120 |
Why?
|
| Reoperation | 2 | 2021 | 4201 | 0.120 |
Why?
|
| Athletes | 1 | 2021 | 1093 | 0.120 |
Why?
|
| Osteochondrosis | 1 | 2013 | 6 | 0.110 |
Why?
|
| Fractures, Ununited | 1 | 2015 | 165 | 0.110 |
Why?
|
| Orthopedic Equipment | 1 | 2013 | 22 | 0.110 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 133 | 0.110 |
Why?
|
| Kyphosis | 1 | 2015 | 237 | 0.110 |
Why?
|
| Bone Plates | 1 | 2016 | 468 | 0.110 |
Why?
|
| Spine | 1 | 2020 | 1144 | 0.110 |
Why?
|
| Bone Diseases | 3 | 2016 | 416 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2016 | 376 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.100 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 130 | 0.100 |
Why?
|
| Myelin Proteins | 1 | 2012 | 215 | 0.100 |
Why?
|
| Electronic Health Records | 2 | 2021 | 4468 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2016 | 944 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 550 | 0.090 |
Why?
|
| Recurrence | 2 | 2020 | 8340 | 0.090 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2012 | 231 | 0.090 |
Why?
|
| Male | 26 | 2021 | 350118 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1622 | 0.080 |
Why?
|
| Child, Preschool | 13 | 2018 | 41006 | 0.080 |
Why?
|
| Female | 28 | 2021 | 380194 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 2529 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13102 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 1392 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2022 | 11483 | 0.080 |
Why?
|
| Sclerotherapy | 2 | 2019 | 175 | 0.080 |
Why?
|
| Infant | 11 | 2018 | 35136 | 0.080 |
Why?
|
| Arthritis, Infectious | 1 | 2011 | 367 | 0.080 |
Why?
|
| Orthopedics | 1 | 2016 | 904 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3279 | 0.070 |
Why?
|
| Spinal Fusion | 1 | 2015 | 1241 | 0.070 |
Why?
|
| Rats | 1 | 2022 | 24260 | 0.070 |
Why?
|
| Radiography | 5 | 2015 | 7023 | 0.070 |
Why?
|
| Lyme Disease | 1 | 2011 | 621 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2376 | 0.070 |
Why?
|
| Bone Screws | 2 | 2021 | 520 | 0.060 |
Why?
|
| Hip Joint | 1 | 2011 | 1002 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 794 | 0.060 |
Why?
|
| Animals | 5 | 2023 | 168757 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15295 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39050 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 1213 | 0.050 |
Why?
|
| Time Factors | 8 | 2018 | 40075 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2016 | 1107 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3396 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 53288 | 0.050 |
Why?
|
| Mutation | 3 | 2020 | 29786 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3507 | 0.050 |
Why?
|
| DNA | 1 | 2015 | 7301 | 0.050 |
Why?
|
| Pigmentation | 1 | 2021 | 148 | 0.050 |
Why?
|
| Coloboma | 1 | 2020 | 54 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12959 | 0.050 |
Why?
|
| Syndrome | 1 | 2006 | 3251 | 0.040 |
Why?
|
| Multipotent Stem Cells | 1 | 2021 | 186 | 0.040 |
Why?
|
| False Positive Reactions | 2 | 2013 | 981 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2015 | 890 | 0.040 |
Why?
|
| Arthrodesis | 1 | 2021 | 189 | 0.040 |
Why?
|
| Larva | 1 | 2021 | 519 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 81183 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2017 | 40561 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7279 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 895 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2020 | 302 | 0.040 |
Why?
|
| Phlebography | 1 | 2018 | 333 | 0.040 |
Why?
|
| Osteonecrosis | 2 | 2009 | 227 | 0.040 |
Why?
|
| Diaphyses | 1 | 2016 | 65 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2018 | 520 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 1266 | 0.040 |
Why?
|
| Young Adult | 7 | 2018 | 56430 | 0.030 |
Why?
|
| Bone Nails | 1 | 2016 | 219 | 0.030 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 1681 | 0.030 |
Why?
|
| Elasticity | 1 | 2016 | 657 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1701 | 0.030 |
Why?
|
| Calcaneus | 1 | 2015 | 138 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 15540 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 662 | 0.030 |
Why?
|
| Recovery of Function | 2 | 2017 | 2925 | 0.030 |
Why?
|
| Casts, Surgical | 1 | 2014 | 178 | 0.030 |
Why?
|
| Narration | 1 | 2014 | 212 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2018 | 1462 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2504 | 0.030 |
Why?
|
| Boston | 2 | 2018 | 9313 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2011 | 231 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 761 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 569 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2011 | 394 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 1475 | 0.020 |
Why?
|
| Mosaicism | 1 | 2012 | 441 | 0.020 |
Why?
|
| Exostoses | 1 | 2008 | 30 | 0.020 |
Why?
|
| Polysomnography | 1 | 2015 | 1776 | 0.020 |
Why?
|
| Adult | 6 | 2018 | 214055 | 0.020 |
Why?
|
| Switzerland | 1 | 2009 | 255 | 0.020 |
Why?
|
| Arthrography | 1 | 2008 | 149 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1588 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2013 | 25625 | 0.020 |
Why?
|
| Checklist | 1 | 2014 | 833 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 1442 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15076 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2714 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 1979 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 6309 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 1257 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.010 |
Why?
|
| Wound Healing | 1 | 2015 | 2785 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4186 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3558 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2018 | 4599 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3743 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 35421 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 1578 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 2008 | 917 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3494 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2009 | 1095 | 0.010 |
Why?
|
| Risk Factors | 2 | 2018 | 72290 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18370 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 29144 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2795 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20947 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5078 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3420 | 0.010 |
Why?
|
| Research Design | 1 | 2014 | 5987 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8949 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20129 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7181 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|